Crush Your Exit: Ready Your Finances for IPO or Acquisition

Hosted by Silicon Valley Bank and First Citizens Wealth

Webinar | May.16.2024 | 1pm - 2pm (Eastern Standard Time)

Companies that put their public offering and acquisition plans on ice since 2022 are starting to plan for a thaw. If your company is considering exit options through M&A or IPO, mark your calendars for this webinar as we explore what has changed since the window slammed shut.

Key takeaways

Key legal insights for IPO readiness
The time and financial resources required for preparation
Personal financial planning essentials
Preparing your executive team for post-exit realities
Fine tuning your cap table and equity compensation plans

Featured panelists

Albert Vanderlaan – Practice Group Leader, Capital Markets, Orrick
Ann Lucchesi – Managing Director, First Citizens Wealth
Tracy Knox – Former CFO at Rover Group
Evan Fein – CFO at TextNow
Jack Gaziano – Head of Relationship Management, Corporate Banking, Silicon Valley Bank

You should attend if...

You want to get your financials in order before the IPO window reopens. The discussion will be most relevant for CFOs, corporate finance leaders, human resources executives, and legal executives of Series B and C companies with an IPO or M&A on the horizon.

Watch the recording

Contacts

Albert Vanderlaan Partner, Capital Markets, Corporate Governance

Boston

See my bio

D:+1 617 880 2219
E: [email protected]

Practice:

Technology & Innovation Sector
Capital Markets
Corporate Governance
Technology Companies Group
Life Sciences & HealthTech
Special Purpose Acquisition Companies (SPACs)
Mergers & Acquisitions

vCard

See full bio

Albert Vanderlaan Partner

Boston

Albert is involved in a broad range of corporate legal engagements for high growth technology companies, including IPOs, follow-on public offerings, private and public company securities law compliance matters, public company disclosure obligations, de-SPAC transactions, SPAC IPOs, venture financings and mergers and acquisitions. He also regularly advises public and private companies and their boards of directors on corporate governance issues.

Albert's clients include public and private companies in technology, automotive, Internet related industries, real estate, finance and the life sciences (including, among others, immuno-oncology, gene therapy, restorative cell therapy and medical device companies). He also represents underwriters in initial public offerings, follow-on offerings and PIPE offerings and venture capital firms in a variety of investment transactions.

Albert was named to the Deal’s Top Rising Stars 2021 list, which recognizes top new partners at U.S. law firms who are “doing spectacular work in the field of deal-making and who have continued to progress in their career despite the obstacles put in front of them.”